International registry for congenital portosystemic shunt
Part of Brain & nervous system, Cancer, Digestive system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This registry is gathering information from people who have a rare liver blood vessel problem they were born with (congenital portosystemic shunt). By joining, you help researchers learn more about this condition and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a congenital portosystemic shunt (a blood vessel abnormality in the liver that you were born with).
- Your shunt must not be caused by another condition (like a secondary shunt from surgery or injury).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for genetic causes of a rare combination of conditions: a liver blood vessel problem (congenital portosystemic shunt) and high blood pressure in the lungs (portopulmonary hypertension). It requires both parents and a sibling to also give blood samples so researchers can compare genes within the family.
This is a registry study that collects information from people who need a procedure called TIPS for portal hypertension. It may help doctors better understand outcomes and care for both cirrhotic and non-cirrhotic causes of portal hypertension.
This study is a registry, meaning it collects health information to better understand people who have a TIPS procedure for high pressure in the liver’s blood vessels. It may help doctors improve how TIPS is used and monitored over time.
This study looks at people with a rare liver condition called porto-sinusoidal vascular disorder (PSVD), which affects blood flow in the liver. It aims to learn more about what causes it and how it affects patients over time.
This study is a registry, meaning it collects health information to better understand congenital central hypoventilation syndrome (CCHS). It enrolls only people whose CCHS has been confirmed by a PHOX2B gene test.
This study looks at people who have both liver blood vessel issues and high blood pressure in the lungs. It aims to learn more about this condition and how it affects people over time, which may help improve future care.
Hear when a new Congenital Portosystemic Shunt trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.